Screener
10x Genomics, Inc. TXG Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $20,694 | $12,733 |
| Accrued compensation and related benefits | 24,744 | 42,500 |
| Accrued expenses and other current liabilities | 30,377 | 39,971 |
| Deferred revenue | 23,610 | 23,902 |
| Operating lease liabilities | 12,015 | 10,985 |
| Contingent consideration, current | 7,069 | 23,363 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is 10x Genomics, Inc.'s accrued manufacturing costs?
- 10x Genomics, Inc. (TXG) reported accrued manufacturing costs of $24.74M in Q2 2026.
- How has 10x Genomics, Inc.'s accrued manufacturing costs changed year-over-year?
- 10x Genomics, Inc.'s accrued manufacturing costs decreased by 5.2% year-over-year, from $26.1M to $24.74M.
- What is the long-term trend for 10x Genomics, Inc.'s accrued manufacturing costs?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s accrued manufacturing costs has grown at a 22.5% compound annual growth rate (CAGR), from $15.38M to $42.5M.
- What does accrued manufacturing costs mean?
- Accrued liabilities related to manufacturing and production activities.
Ask your AI about 10x Genomics, Inc.'s accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude